Big Sponsors

The SpaceX Dragon spacecraft nears the International Space Station during the CRS-8 mission to deliver experiments and supplies to the International Space Station. (Image credit: NASA)

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

By Melissa Fassbender

Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

While the renewals are a topic of concern for investors, analysts believe both CROs will see a re-up. (Image: iStock/shironosov)

Will Pfizer renew with Icon, Parexel? Analyst says yes

By Melissa Fassbender

This month marks the renewal period for Pfizer’s contract research organizations’ Icon and Parexel, and while revenues have been declining, analysts believe the pharma giant will renew with both companies.